Clinical Trials
5 trialsNCT00864318 2026-04-14
TICE
Institut Claudius Regaud
Phase 2 Completed
NCT07423078 2026-04-13
WOLF
University of Pittsburgh
Phase 2 Recruiting
NCT03315364 2026-04-01
OPTIMAL
Daehwa Pharmaceutical Co., Ltd.
Phase 2/3 Active not recruiting
NCT06052839 2026-02-09
Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC
University of Pittsburgh
Phase 2 Recruiting
NCT03981796 2025-09-03
RUBY
Tesaro, Inc.
Phase 3 Active not recruiting